You're contacting media contact of this press release

Title: Microsoft Spotlights Netwoven for Securing Rare-Disease Biotech Soleno Therapeutics

United States, 19th Jun 2026 — Netwoven, a global Microsoft Solutions Partner, today announced that Microsoft has published a customer story featuring Netwoven's work with Soleno Therapeutics, a rare-disease biotechnology company. The story details how Netwoven deployed Microsoft Defender and Purview Suite for Business Premium to unify security and information governance across Soleno's regulated, multi-region environment.Soleno faced a challenge common to fast-scaling, highly regulated organizations: a patchwork of disconnected security tools with no single view of access, and sensitive clinical, regulatory, and financial data spread across systems. Working with Netwoven, Soleno consolidated identity, endpoint, data, and collaboration protection into one continuously monitored platform — giving a lean IT team enterprise-grade visibility and control.The deployment introduced tiered data labeling from "Public" to "High Risk," built-in EU data residency for Soleno's Dublin office using Microsoft Multi-Geo, and flexible controls aligned with EMA and Sarbanes-Oxley requirements. The impact extended beyond security: Soleno's IT team shifted from fielding daily access tickets to driving strategic initiatives."Being recognized by Microsoft reflects the outcomes our customers achieve every day," said Niraj Tenany, CEO, Netwoven.The full story is available at https://www.microsoft.com/en/customers/story/26639-soleno-life-microsoft-365-business-premium.About NetwovenNetwoven is a global Microsoft Solutions Partner founded in 2001 by senior executives from Microsoft, Oracle, and Intel. Headquartered in the San Francisco Bay Area with delivery centers across the U.S., India, and Europe, Netwoven helps organizations collaborate securely, modernize systems, and reduce cyber...

This press release is issued by King Newswire